v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 5,450 3,600 10,828 7,036
General and administrative 2,103 2,091 4,591 4,568
Depreciation and amortization 8 29 16 59
Total operating expenses 7,561 5,720 15,435 11,663
Loss from operations (7,561) (5,720) (15,435) (11,663)
Other income (loss):        
Gain (loss) from change in fair value of warrant liability (7) (560) 10,763 (560)
Transaction costs allocated to warrant liabilities (2) (1,207) (695) (1,207)
Loss on issuance of warrant liabilities 0 (10,352) (15,158) (10,352)
Other income, net 13 4 88 13
Interest income (expense), net (78) 26 (43) 56
Net loss (7,635) (17,809) (20,480) (23,713)
Warrant deemed dividend (329) 0 (2,094) 0
Net loss available to common stockholders $ (7,964) $ (17,809) $ (22,574) $ (23,713)
Net loss per common share - basic and diluted (in dollars per share) $ (1.4) $ (28.68) $ (4.6) $ (47.61)
Weighted average common shares outstanding, basic and diluted (in shares) 5,680,717 621,056 4,906,899 498,087
Net loss $ (7,635) $ (17,809) $ (20,480) $ (23,713)
Other comprehensive income (loss):        
Foreign currency translation (12) 0 (74) 3
Comprehensive loss $ (7,647) $ (17,809) $ (20,554) $ (23,710)